REAGENT / VECTOR CORE

$2P01FY2012ARNIH

Univ Of Massachusetts Med Sch Worcester, Worcester MA

Investigators

Linked publications & trials

Paper 32286184 Paper 32191633 Paper 31534009 Paper 29150239 Paper 28346226 Paper 28239656 Paper 27740718 Paper 27531928 Paper 27354219 Paper 26808498 Paper 26803634 Paper 26729810 Paper 26457825 Paper 26432899 Paper 26315890 Paper 26268653 Paper 25681333 Paper 25646421 Paper 25601924 Paper 25595782 Paper 25548216 Paper 25416804 Paper 25279834 Paper 25187660 Paper 25076492 Paper 24957237 Paper 24914072 Paper 24456224 Paper 23918976 Paper 23804807 Paper 23499488 Paper 23467932 Paper 23296704 Paper 23291967 Paper 23144495 Paper 23100627 Paper 23019335 Paper 22577035 Paper 22430248 Paper 22354320 Paper 22323842 Paper 22285306 Paper 21628334 Paper 21306913 Paper 20809520 Paper 20624888 Paper 20613770 Paper 20089701 Paper 20014975 Paper 20014959 Paper 20007534 Paper 19864612 Paper 19800208 Paper 19648272 Paper 19587008 Paper 19378022 Paper 19124725 Paper 18941176 Paper 18691914 Paper 18199415 Paper 18034429 Paper 18025183 Paper 17276080 Paper 17254393 Paper 16973389 Paper 16530602 Paper 16260486 Paper 16027240

Abstract

The overarching main objective of this Program Project is to understand the mechanisms through which autoantigen/autoantibody complexes contribute to the initiation and/or maintainence of systemic lupus erythematosus. The various projects in the Program will rely, in part, on a number of antigens, antibodies and viral vectors to carry out the proposed specific aims. The successful completion of these aims has been and will continue to be enhanced by the availability of a set of highly defined, quality controlled reagents that will be produced by this Core.

View original record on NIH RePORTER →